Abstract
The pathogenic protozoa responsible for malaria lack enzymes for the de novo synthesis of purines and rely on purine salvage from the host. In Plasmodium falciparum (Pf), hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) converts hypoxanthine to inosine monophosphate and is essential for purine salvage making the enzyme an anti-malarial drug target. We have synthesized a number of simple acyclic aza-C-nucleosides and shown that some are potent inhibitors of Pf HGXPRT while showing excellent selectivity for the Pf versus the human enzyme.
Original language | English (US) |
---|---|
Pages (from-to) | 5629-5646 |
Number of pages | 18 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 21 |
Issue number | 17 |
DOIs | |
State | Published - Sep 1 2013 |
Externally published | Yes |
Keywords
- HGXPRTase
- Malaria
- Phosphoribosyltransferase
- Protozoa
- Purine salvage
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry